Literature DB >> 29405315

Comparative study of cyto- and genotoxic potential with mechanistic insights of tungsten oxide nano- and microparticles in lung carcinoma cells.

Srinivas Chinde1,2, Y Poornachandra1, Archana Panyala1, Srinivas Indu Kumari1, Suresh Yerramsetty3, Harikrishna Adicherla4, Paramjit Grover1.   

Abstract

The exigency of semiconductor and super capacitor tungsten oxide nanoparticles (WO3 NPs) is increasing in various sectors. However, limited information on their toxicity and biological interactions are available. Hence, we explored the underlying mechanisms of toxicity induced by WO3 NPs and their microparticles (MPs) using different concentrations (0-300 μg ml-1 ) in human lung carcinoma (A549) cells. The mean size of WO3 NPs and MPs by transmission electron microscopy was 53.84 nm and 3.88 μm, respectively. WO3 NPs induced reduction in cell viability, membrane damage and the degree of induction was size- and dose-dependent. There was a significant increase in the percentage tail DNA and micronuclei formation at 200 and 300 μg ml-1 after 24 hours of exposure. The DNA damage induced by WO3 NPs could be attributed to increased oxidative stress and inflammation through reactive oxygen species generation, which correlated with the depletion of reduced glutathione content, catalase and an increase in malondialdehyde levels. Cellular uptake studies unveiled that both the particles were attached/surrounded to the cell membrane according to their size. In addition, NP inhibited the progression of the cell cycle in the G2 /M phase. Other studies such as caspase-9 and -3 and Annexin-V-fluorescein isothiocyanate revealed that NPs induced intrinsic apoptotic cell death at 200 and 300 μg ml-1 concentrations. However, in comparison to NPs, WO3 MPs did not incite any toxic effects at the tested concentrations. Under these experimental conditions, the no-observed-significant-effect level of WO3 NPs was determined to be ≤200 μg ml-1 in A549 cells.
Copyright © 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  apoptosis; cellular uptake; cytotoxicity; genotoxicity; human lung carcinoma cells; oxidative stress; tungsten oxide nanoparticles

Year:  2018        PMID: 29405315     DOI: 10.1002/jat.3598

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  4 in total

1.  Inhalation of Tungsten Metal Particulates Alters the Lung and Bone Microenvironments Following Acute Exposure.

Authors:  Kara Miller; Charlotte M McVeigh; Edward B Barr; Guy W Herbert; Quiteria Jacquez; Russell Hunter; Sebastian Medina; Selita N Lucas; Abdul-Mehdi S Ali; Matthew J Campen; Alicia M Bolt
Journal:  Toxicol Sci       Date:  2021-11-24       Impact factor: 4.109

2.  In Vitro Analysis of the Effects of ITER-Like Tungsten Nanoparticles: Cytotoxicity and Epigenotoxicity in BEAS-2B Cells.

Authors:  Chiara Uboldi; Marcos Sanles Sobrido; Elodie Bernard; Virginie Tassistro; Nathalie Herlin-Boime; Dominique Vrel; Sébastien Garcia-Argote; Stéphane Roche; Fréderique Magdinier; Gheorghe Dinescu; Véronique Malard; Laurence Lebaron-Jacobs; Jerome Rose; Bernard Rousseau; Philippe Delaporte; Christian Grisolia; Thierry Orsière
Journal:  Nanomaterials (Basel)       Date:  2019-08-30       Impact factor: 5.076

3.  Toxicological Assessment of ITER-Like Tungsten Nanoparticles Using an In Vitro 3D Human Airway Epithelium Model.

Authors:  Isabelle George; Chiara Uboldi; Elodie Bernard; Marcos Sanles Sobrido; Sarah Dine; Agnès Hagège; Dominique Vrel; Nathalie Herlin; Jerome Rose; Thierry Orsière; Christian Grisolia; Bernard Rousseau; Véronique Malard
Journal:  Nanomaterials (Basel)       Date:  2019-09-25       Impact factor: 5.076

4.  Shape-Depended Biological Properties of Ag3PO4 Microparticles: Evaluation of Antimicrobial Properties and Cytotoxicity in In Vitro Model-Safety Assessment of Potential Clinical Usage.

Authors:  Karol P Steckiewicz; Julia Zwara; Maciej Jaskiewicz; Szymon Kowalski; Wojciech Kamysz; Adriana Zaleska-Medynska; Iwona Inkielewicz-Stepniak
Journal:  Oxid Med Cell Longev       Date:  2019-11-20       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.